APA

Li Y., Li Y., Wedrén S., Li G., Charn T. H., Desai K. V., Bonnard C., Czene K., Humphreys K., Darabi H., Einarsdóttir K., Heikkinen T., Aittomäki K., Blomqvist C., Chia K. S., Nevanlinna H., Hall P., Liu E. T. & Liu J. (20140325). Genetic variation of ESR1 and its co-activator PPARGC1B is synergistic in augmenting the risk of estrogen receptor-positive breast cancer. : Breast cancer research : BCR.

Chicago

Li Yuqing, Li Yi, Wedrén Sara, Li Guoliang, Charn Tze Howe, Desai Kartiki Vasant, Bonnard Carine, Czene Kamila, Humphreys Keith, Darabi Hatef, Einarsdóttir Kristjana, Heikkinen Tuomas, Aittomäki Kristiina, Blomqvist Carl, Chia Kee Seng, Nevanlinna Heli, Hall Per, Liu Edison T and Liu Jianjun. 20140325. Genetic variation of ESR1 and its co-activator PPARGC1B is synergistic in augmenting the risk of estrogen receptor-positive breast cancer. : Breast cancer research : BCR.

Harvard

Li Y., Li Y., Wedrén S., Li G., Charn T. H., Desai K. V., Bonnard C., Czene K., Humphreys K., Darabi H., Einarsdóttir K., Heikkinen T., Aittomäki K., Blomqvist C., Chia K. S., Nevanlinna H., Hall P., Liu E. T. and Liu J. (20140325). Genetic variation of ESR1 and its co-activator PPARGC1B is synergistic in augmenting the risk of estrogen receptor-positive breast cancer. : Breast cancer research : BCR.

MLA

Li Yuqing, Li Yi, Wedrén Sara, Li Guoliang, Charn Tze Howe, Desai Kartiki Vasant, Bonnard Carine, Czene Kamila, Humphreys Keith, Darabi Hatef, Einarsdóttir Kristjana, Heikkinen Tuomas, Aittomäki Kristiina, Blomqvist Carl, Chia Kee Seng, Nevanlinna Heli, Hall Per, Liu Edison T and Liu Jianjun. Genetic variation of ESR1 and its co-activator PPARGC1B is synergistic in augmenting the risk of estrogen receptor-positive breast cancer. : Breast cancer research : BCR. 20140325.